Evidence map›Paper›PMID 25035139›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2014

β-Arrestin 2 mediates the anti-inflammatory effects of fluoxetine in lipopolysaccharide-stimulated microglial cells.

Ren-Wei Du, Ren-Hong Du, Wen-Guang Bu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Anti-Neuroinflammatory Effect of Ombuin fromInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Modulation of microglial activation by antidepressants.Journal of psychopharmacology (Oxford, England) · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression.The international journal of neuropsychopharmacology · 2016
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ren-Wei DuDepartment of Neurology, Chaoyang Hospital, 15 Renmingnan Road, Huainan, Anhui, 232007, People's Republic of China.
Ren-Hong Du
Wen-Guang Bu
Huainan Normal University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence has suggested that microglial activation plays an important role in the pathogenesis of depression. Activated microglia can secrete various pro-inflammatory cytokines, which may contribute to the development and maintenance of depression. Thus, inhibition of microglial activation may have a therapeutic benefit in the treatment of depression. In the present study, we found that fluoxetine significantly inhibited lipopolysaccharide (LPS)-induced production of tumor necrosis factor-alpha (TNF-α), interleukin- 6 (IL-6) and nitric oxide (NO) and reduced the phosphorylation of transforming growth factor-beta-activated kinase 1 (TAK1) and nuclear factor-kappa B (NF-κB) p65 nuclear translocation in microglia. We further found that fluoxetine increased the expression of β-arrestin 2 and enhanced the association of β-arrestin 2 with TAK1-binding protein 1 (TAB1) and disrupted TAK1-TAB1 interaction. Moreover, β-arrestin 2 knock-down abolished the anti-inflammatory effects of fluoxetine in lipopolysaccharide-stimulated microglial cells. Collectively, our findings suggest that β-arrestin 2 is necessary for the anti-inflammatory effects of fluoxetine and offers novel drug targets in the convergent fluoxetine/β-arrestin 2 and inflammatory pathways for treating microglial inflammatory neuropathologies like depression.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAnti-Inflammatory Agents, Non-SteroidalArrestinsbeta-Arrestin 2beta-ArrestinsCells, CulturedFluoxetineGene ExpressionGene Knockdown TechniquesInterleukin-6LipopolysaccharidesMaleMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMiceAdaptor Proteins, Signal TransducingAnti-Inflammatory Agents, Non-SteroidalArrb2 protein, mouseArrestinsbeta-Arrestin 2beta-ArrestinsFluoxetineInterleukin-6LipopolysaccharidesMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesNF-kappa BNitric OxideRela protein, mouseTab1 protein, mouseTranscription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID25035139
OpenAlexW2056530469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.